Treatment Strategies in Endogenous Fungal Endophthalmitis

Uveitis Corner: Data from a recent multicenter study reveal substantial variation in initial therapy selection and regional differences in the management of this condition.

By: Arthi Venkat, MD, MS, Eleanor M. Burton, MD

Retinal Physician January 1, 2026 Vol 23, Issue January 2026 Page(s): 20-21

Clinical Report: Treatment Strategies in Endogenous Fungal Endophthalmitis

Overview

This report summarizes findings from a multicenter study on treatment strategies for endogenous fungal endophthalmitis (EFE), highlighting significant variations in therapy selection and outcomes based on clinical characteristics and geographic regions. The study emphasizes the importance of systemic and intravitreal antifungal therapies in managing this vision-threatening condition.

Background

Endogenous fungal endophthalmitis accounts for 5% to 10% of all endophthalmitis cases, often resulting from hematogenous spread of infection. It poses a significant risk to vision, necessitating effective treatment strategies that combine systemic and intraocular therapies. Current guidelines are limited, and there is a need for improved understanding of optimal management approaches.

Data Highlights

{'format': 'Ensure the table is visually clear and accessible.'}

Key Findings

72% of eyes received combination systemic and intravitreal antifungals.
Voriconazole and fluconazole were the most frequently used initial systemic agents.
Patients with positive systemic cultures were more likely to receive IV antifungals.
Only 30% of eyes underwent surgical intervention, with oral therapy associated with higher surgery rates.
Amphotericin B was the most frequently administered intravitreal agent.

Clinical Implications

Clinicians should consider the use of both systemic and intravitreal antifungal therapies in managing EFE, particularly in cases with significant ocular involvement. The choice between oral and IV antifungal agents may depend on culture results and clinical presentation, emphasizing the need for tailored treatment strategies.

Conclusion

The findings from this multicenter study underscore the complexity of managing endogenous fungal endophthalmitis and highlight the necessity for further research to establish clearer guidelines and optimize treatment outcomes.

PentaVision

Retinal Physician